Perceptive Advisors as of March 31, 2024
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 108 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cerevel Therapeutics Hldng I (CERE) | 8.0 | $456M | 11M | 42.27 | |
| Amicus Therapeutics (FOLD) | 5.8 | $331M | 28M | 11.78 | |
| Iovance Biotherapeutics (IOVA) | 5.0 | $286M | 19M | 14.82 | |
| Arcellx Common Stock (ACLX) | 4.8 | $274M | 3.9M | 69.55 | |
| Nuvalent Inc-a (NUVL) | 3.7 | $209M | 2.8M | 75.09 | |
| Inhibrx | 2.6 | $149M | 4.3M | 34.96 | |
| Fusion Pharmaceuticals | 2.5 | $146M | 6.8M | 21.32 | |
| Rhythm Pharmaceuticals (RYTM) | 2.5 | $142M | 3.3M | 43.33 | |
| Apogee Therapeutics (APGE) | 2.4 | $137M | 2.1M | 66.45 | |
| Vaxcyte (PCVX) | 2.3 | $132M | 1.9M | 68.31 | |
| Soleno Therapeutics (SLNO) | 2.3 | $132M | 3.1M | 42.80 | |
| Medtronic SHS (MDT) | 2.2 | $125M | 1.4M | 87.15 | |
| Madrigal Pharmaceuticals (MDGL) | 2.0 | $115M | 430k | 267.04 | |
| Springworks Therapeutics (SWTX) | 1.9 | $111M | 2.3M | 49.22 | |
| Neurocrine Biosciences (NBIX) | 1.9 | $111M | 804k | 137.92 | |
| Immunovant (IMVT) | 1.7 | $99M | 3.1M | 32.31 | |
| Spyre Therapeutics Com New (SYRE) | 1.7 | $97M | 2.6M | 37.93 | |
| Biohaven (BHVN) | 1.7 | $94M | 1.7M | 54.69 | |
| Solid Biosciences Com New (SLDB) | 1.6 | $92M | 6.9M | 13.32 | |
| Astria Therapeutics (ATXS) | 1.6 | $91M | 6.5M | 14.07 | |
| Axsome Therapeutics (AXSM) | 1.5 | $88M | 1.1M | 79.80 | |
| Viking Therapeutics (VKTX) | 1.4 | $82M | 994k | 82.00 | |
| Evolus (EOLS) | 1.4 | $81M | 5.8M | 14.00 | |
| Lyra Therapeutics (LYRA) | 1.4 | $79M | 13M | 6.22 | |
| Disc Medicine (IRON) | 1.4 | $77M | 1.2M | 62.26 | |
| Cargo Therapeutics (CRGX) | 1.3 | $77M | 3.4M | 22.32 | |
| Intra Cellular Therapies (ITCI) | 1.3 | $73M | 1.1M | 69.20 | |
| Natera (NTRA) | 1.2 | $69M | 757k | 91.46 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.2 | $69M | 1.5M | 46.81 | |
| Meiragtx Holdings (MGTX) | 1.2 | $69M | 11M | 6.07 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $68M | 526k | 129.46 | |
| Miragen Therapeutics (VRDN) | 1.1 | $64M | 3.7M | 17.51 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.1 | $61M | 3.8M | 16.09 | |
| Applied Therapeutics (APLT) | 1.0 | $58M | 8.5M | 6.80 | |
| Cg Oncology (CGON) | 1.0 | $57M | 1.3M | 43.90 | |
| CryoLife (AORT) | 1.0 | $57M | 2.7M | 21.16 | |
| Arvinas Ord (ARVN) | 0.9 | $51M | 1.2M | 41.28 | |
| Celcuity (CELC) | 0.9 | $51M | 2.4M | 21.60 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.9 | $50M | 822k | 61.02 | |
| Rocket Pharmaceuticals (RCKT) | 0.8 | $49M | 1.8M | 26.94 | |
| Immatics SHS (IMTX) | 0.8 | $48M | 4.6M | 10.51 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $47M | 1.3M | 36.35 | |
| Bridgebio Pharma (BBIO) | 0.8 | $44M | 1.4M | 30.92 | |
| Adma Biologics (ADMA) | 0.7 | $43M | 6.4M | 6.60 | |
| Edgewise Therapeutics (EWTX) | 0.7 | $42M | 2.3M | 18.24 | |
| Verrica Pharmaceuticals (VRCA) | 0.7 | $42M | 7.1M | 5.92 | |
| Intuitive Surgical Com New (ISRG) | 0.7 | $41M | 102k | 399.09 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $38M | 892k | 43.05 | |
| Nautilus Biotechnology (NAUT) | 0.6 | $37M | 13M | 2.94 | |
| Akero Therapeutics (AKRO) | 0.6 | $35M | 1.4M | 25.26 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.6 | $35M | 3.1M | 11.30 | |
| Landos Biopharma Com New | 0.6 | $32M | 1.5M | 21.48 | |
| Ocular Therapeutix (OCUL) | 0.5 | $30M | 3.3M | 9.10 | |
| Treace Med Concepts (TMCI) | 0.5 | $30M | 2.3M | 13.05 | |
| Cabaletta Bio (CABA) | 0.5 | $29M | 1.7M | 17.06 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $29M | 994k | 28.93 | |
| Irhythm Technologies (IRTC) | 0.5 | $28M | 245k | 116.00 | |
| Aldeyra Therapeutics (ALDX) | 0.5 | $28M | 8.6M | 3.27 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.5 | $28M | 4.3M | 6.38 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.4 | $22M | 3.0M | 7.15 | |
| Pepgen (PEPG) | 0.4 | $21M | 1.4M | 14.70 | |
| Revolution Medicines (RVMD) | 0.3 | $20M | 619k | 32.23 | |
| Abbvie (ABBV) | 0.3 | $19M | 107k | 182.10 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.3 | $17M | 339k | 50.23 | |
| Engene Holdings (ENGN) | 0.3 | $17M | 999k | 16.95 | |
| Livanova SHS (LIVN) | 0.3 | $17M | 299k | 55.94 | |
| Athira Pharma (ATHA) | 0.3 | $15M | 5.4M | 2.74 | |
| Tactile Systems Technology, In (TCMD) | 0.3 | $15M | 903k | 16.25 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.2 | $13M | 2.5M | 5.27 | |
| Axogen (AXGN) | 0.2 | $13M | 1.6M | 8.07 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $12M | 590k | 20.67 | |
| Zymeworks Del (ZYME) | 0.2 | $11M | 1.1M | 10.52 | |
| Rapt Therapeutics (RAPT) | 0.2 | $11M | 1.2M | 8.98 | |
| Tyra Biosciences (TYRA) | 0.2 | $11M | 669k | 16.40 | |
| Procept Biorobotics Corp (PRCT) | 0.2 | $10M | 211k | 49.42 | |
| Morphic Hldg (MORF) | 0.2 | $10M | 288k | 35.20 | |
| Silverback Therapeutics (SPRY) | 0.2 | $8.9M | 867k | 10.22 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $7.4M | 750k | 9.91 | |
| Arrivent Biopharma (AVBP) | 0.1 | $7.4M | 415k | 17.86 | |
| Precision Biosciences Com New (DTIL) | 0.1 | $6.5M | 481k | 13.56 | |
| Cogent Biosciences (COGT) | 0.1 | $5.9M | 883k | 6.72 | |
| Kalvista Pharmaceuticals (KALV) | 0.1 | $5.9M | 500k | 11.86 | |
| Immunitybio (IBRX) | 0.1 | $5.7M | 1.1M | 5.37 | |
| Amylyx Pharmaceuticals Call Option (AMLX) | 0.1 | $5.6M | 2.0M | 2.84 | |
| Macrogenics (MGNX) | 0.1 | $5.6M | 378k | 14.72 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.1 | $5.2M | 500k | 10.40 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $4.9M | 3.5M | 1.39 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.1 | $4.7M | 50k | 94.89 | |
| Establishment Labs Holdings Ord (ESTA) | 0.1 | $4.2M | 82k | 50.90 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.1 | $4.1M | 175k | 23.65 | |
| Absci Corp (ABSI) | 0.1 | $4.0M | 700k | 5.68 | |
| Female Health (VERU) | 0.1 | $3.9M | 5.6M | 0.70 | |
| Kyverna Therapeutics (KYTX) | 0.1 | $3.7M | 150k | 24.84 | |
| Trinity Biotech Spons Adr New (TRIB) | 0.1 | $3.7M | 1.8M | 2.04 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.1 | $3.6M | 555k | 6.50 | |
| Envveno Medical (NVNO) | 0.1 | $3.4M | 623k | 5.44 | |
| Novavax Com New Put Option (NVAX) | 0.1 | $3.3M | 700k | 4.78 | |
| Revance Therapeutics (RVNC) | 0.1 | $3.0M | 600k | 4.92 | |
| Agios Pharmaceuticals Call Option (AGIO) | 0.1 | $2.9M | 100k | 29.24 | |
| Forte Biosciences (FBRX) | 0.0 | $2.3M | 3.3M | 0.70 | |
| Singular Genomics Systems In | 0.0 | $1.1M | 2.1M | 0.51 | |
| Kura Oncology (KURA) | 0.0 | $1.0M | 48k | 21.33 | |
| Vbi Vaccines Inc Cda Com New (VBIVQ) | 0.0 | $757k | 1.3M | 0.60 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.0 | $625k | 117k | 5.35 | |
| Caremax Cl A New (CMAX) | 0.0 | $591k | 123k | 4.82 | |
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $46k | 250k | 0.18 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $5.0k | 167k | 0.03 | |
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $1.0k | 60k | 0.02 |
